Y-K. Kang - Asan Medical Center, University of Ulsan

Y-K. Kang,S. Qin,K-W. Lee,S. C. Oh,I-H. Kim, J. G. Kim, Y. Li, Z. Yan, J. Li,L-Y. Bai,C. P. K. Chan, A. Yusuf, A. Zahlten-Kuemeli, K. Taylor, K. Yamaguchi

ANNALS OF ONCOLOGY (2023): S1525-S1525

Cited0Views0Bibtex

F. Lordick,E. Van Cutsem,K. Shitara,R-H. Xu,J.A. Ajani,M.A. Shah, M. Oh, A. Ganguli,S. Rhoten, P. Bhattacharya,M. Matsangou, J.W. Park,Y-K. Kang

Annals of Oncology (2023): S860-S861

Cited0Views0Bibtex

1518P Zanidatamab (zani) Plus Chemotherapy (chemo) and Tislelizumab (tis) As First-Line (1l) Therapy for Patients (pts) with Advanced HER2-positive (+) Gastric/gastroesophageal Junction Adenocarcinoma (GC/GEJC): Updated Results from a Phase Ib/II Study

K-W. Lee,L-Y. Bai, M. Jung,J. Ying,Y-H. Im,D-Y. Oh,J.Y. Cho,S.C. Oh, Y. Chao, P. Zhou, Y. Bao,Y-K. Kang

Annals of Oncology (2023): S855-S856

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn